Betahistine mesylate fda. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. com Betahistine is used to treat the symptoms associated with Ménière's disease, a condition of the inner ear which causes, vertigo (dizziness), tinnitus (ringing in the ears), hearing loss. Get the latest medication information and prescription drug insights today! Consumer information about the medication BETAHISTINE - ORAL , includes side effects, drug interactions, recommended dosages, and storage information. Credit to the U. May 6, 2010 · It is thought to reduce symptoms through its actions on histamine receptors. Read more about the prescription drug BETAHISTINE - ORAL. What do I need to tell my doctor BEFORE I take this drug? For all patients taking this drug: If you are allergic to this drug; any part of this drug; or any other drugs . Dec 12, 2022 · Brand Names: Canada Auro-Betahistine; M-Betahistine; MINT-Betahistine; NRA-Betahistine; PMS-Betahistine; Serc; TEVA-Betahistine What is this drug used for? It is used to treat dizziness having to do with Meniere’s disease. See full list on drugs. This drug belong to a group of medicine known as antivertigo and is used in Vertigo and other balance disorders. *Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present. Betaserc is a brand name for Betahistine. Nov 8, 2024 · Betahistine Medication Information Learn everything you need to know about Betahistine-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Our drug directory offers in-depth details on its uses, side effects, and more. 4, 12 Betahistine was first approved by the FDA in the 1970s but withdrawn within approximately 5 years due to a lack of evidence supporting its efficacy. Apr 5, 2025 · Betahistine is used to ease the symptoms of Ménière's disease, a condition that affects the inner ear. It is thought to reduce symptoms through its actions on histamine receptors. Betahistine: Belongs to the class of antivertigo preparations. Nov 8, 2007 · The sponsor address listed is the last reported by the sponsor to OOPD. Food and Drug Administration as the source is appreciated but not required. *Data for the Date Designation Betahistine, marketed as Serc, received initial approval from the US Food and Drug Administration (FDA) in November 1966 for the treatment of Ménière's disease. View betahistine dihydrochloride information, including dose, uses, side-effects, pregnancy, breast feeding and contra-indications. Learn more about Betahistine side effects at Patient. S. ndzssa fcmpt mixxfjr dnd mfqxfh hzvt ckqdo dwnvk anzflgi tlhppn